XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows from Operating Activities of Continuing Operations    
Net income from continuing operations $ 8,256 $ 3,963
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities of continuing operations:    
Amortization 1,163 871
Depreciation 895 749
Intangible asset impairment charges 23 0
Loss (income) from investments in equity securities, net 991 (854)
Charge for the acquisition of Pandion Therapeutics, Inc. 0 1,556
Deferred income taxes (600) 29
Share-based compensation 257 243
Other 776 328
Net changes in assets and liabilities (2,698) (3,655)
Net Cash Provided by Operating Activities of Continuing Operations 9,063 3,230
Cash Flows from Investing Activities of Continuing Operations    
Capital expenditures (2,113) (2,068)
Purchases of securities and other investments (705) (1)
Proceeds from sales of securities and other investments 374 386
Acquisition of Pandion Therapeutics, Inc., net of cash acquired 0 (1,554)
Other acquisitions, net of cash acquired 0 (90)
Other 194 16
Net Cash Used in Investing Activities of Continuing Operations (2,250) (3,311)
Cash Flows from Financing Activities of Continuing Operations    
Net change in short-term borrowings 0 (3,983)
Payments on debt (1,250) (1,153)
Distribution from Organon & Co. 0 9,000
Purchases of treasury stock 0 (239)
Dividends paid to stockholders (3,515) (3,318)
Proceeds from exercise of stock options 109 51
Other (207) (194)
Net Cash (Used in) Provided by Financing Activities of Continuing Operations (4,863) 164
Cash Flows from Discontinued Operations    
Net cash provided by operating activities 0 1,051
Net cash used in investing activities 0 (134)
Net cash used in financing activities 0 (504)
Net Cash Flows Provided by Discontinued Operations 0 413
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (364) (19)
Net Increase in Cash, Cash Equivalents and Restricted Cash 1,586 477
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $71 and $103 at January 1, 2022 and 2021, respectively, included in Other current assets) 8,167 8,153
Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $78 and $55 at June 30, 2022 and 2021, respectively, included in Other current assets) $ 9,753 $ 8,630